무릎용 히알루론산 주사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Knee Hyaluronic Acid Injections Market size is expected to reach USD 3.35 Billion in 2034 from USD 1.96 Billion (2025) growing at a CAGR of 6.12% during 2026-2034.

The global knee hyaluronic acid injections market is experiencing strong growth due to the increasing prevalence of osteoarthritis and joint-related disorders. These injections are used to relieve pain and improve joint mobility by lubricating the knee joint. The growing aging population and rising demand for non-surgical treatment options are key factors driving market expansion. Additionally, increasing awareness about early intervention and joint care is supporting demand.

Key growth drivers include advancements in injectable formulations and the increasing preference for minimally invasive treatments. Hyaluronic acid injections provide temporary relief and delay the need for surgical procedures, making them widely accepted among patients. The expansion of healthcare infrastructure and increasing access to orthopedic treatments are also contributing to market growth. Furthermore, ongoing research is improving product efficacy and duration of relief.

Looking ahead, the knee hyaluronic acid injections market is expected to grow steadily with continuous advancements in treatment technologies. The development of longer-lasting and more effective formulations will further drive adoption. Emerging markets are likely to provide significant growth opportunities due to rising healthcare awareness. Additionally, increasing focus on preventive care and early diagnosis will support market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Single Injection Knee Hyaluronic Acid Injections
• Three Injection Knee Hyaluronic Acid Injections
• Five Injection Knee Hyaluronic Acid Injections
• Next Generation (Steroid Combination)

By End User

• Hospitals
• Ambulatory Surgical Centers
• Orthopedic Clinics
• Retail Pharmacies
• Online Sales

COMPANIES PROFILED

• Sanofi SA, Bioventus LLC, Ferring BV, Zimmer Biomet, Seikagaku Corporation, Fidia Farmaceutici spa, Anika Therapeutics Inc, LG Chem, OrthogenRx, Hanmi Pharm Co Ltd, Chugai Pharmaceutical Co Ltd, Haohai Biological Technology
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL KNEE HYALURONIC ACID INJECTIONS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Single Injection Knee Hyaluronic Acid Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Three Injection Knee Hyaluronic Acid Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Five Injection Knee Hyaluronic Acid Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Next Generation (Steroid Combination) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL KNEE HYALURONIC ACID INJECTIONS MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Orthopedic Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Online Sales Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL KNEE HYALURONIC ACID INJECTIONS MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End User
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End User
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End User
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End User
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End User
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL KNEE HYALURONIC ACID INJECTIONS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Sanofi S.A
  • 8.2.2 Bioventus LLC
  • 8.2.3 Ferring B.V
  • 8.2.4 Zimmer Biomet
  • 8.2.5 Seikagaku Corporation
  • 8.2.6 Fidia Farmaceutici S.p.a
  • 8.2.7 Anika Therapeutics Inc
  • 8.2.8 LG Chem
  • 8.2.9 OrthogenRx
  • 8.2.10 Hanmi Pharm. Co. Ltd
  • 8.2.11 Chugai Pharmaceutical Co. Ltd
  • 8.2.12 Haohai Biological Technology